2 in 1 Dandruff
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- 2 in 1 Dandruff
- Generic name
- PYRITHIONE ZINC
- Manufacturer
- Target Corporation
- Product type
- HUMAN OTC DRUG
- SPL set ID
- a9d92e08-a77f-45dd-b95a-9923202df40b
- SPL ID
- 4ffd8965-0869-09db-e063-6394a90a9ba2
- Version
- 16
- Effective date
- 2026-04-21
- Source export date
- 2026-10-12
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:02:29
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M032 | openfda.application_number | |
| brand name | 2 in 1 Dandruff | openfda.brand_name | |
| generic name | PYRITHIONE ZINC | openfda.generic_name | |
| manufacturer name | Target Corporation | openfda.manufacturer_name | |
| ndc | package | 11673-643-86 | openfda.package_ndc |
| ndc | package | 11673-643-11 | openfda.package_ndc |
| ndc | product | 11673-643 | openfda.product_ndc |
| ndc11 | package | 11673064386 | derived:openfda.package_ndc |
| ndc11 | package | 11673064311 | derived:openfda.package_ndc |
| rxcui | 209884 | openfda.rxcui | |
| spl id | 4ffd8965-0869-09db-e063-6394a90a9ba2 | id | |
| spl set id | a9d92e08-a77f-45dd-b95a-9923202df40b | set_id | |
| unii | R953O2RHZ5 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings For external use only
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions Dist. by Target Corp., Mpls., MN 55403 Made in the U.S.A. with U.S. and foreign components TM & © 2025 Target Brands, Inc.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.